Edaravone | B2024

Edaravone is a low-molecular-weight antioxidant drug targeting peroxyl radicals among many types of reactive oxygen species. Most notably, it reduces damage due to ischemia-reperfusion injury in lung, liver, and brain in animal models of transplant, infection, traumatic brain injury, and stroke.

Edaravone is a low-molecular-weight antioxidant drug targeting peroxyl radicals among many types of reactive oxygen species. Most notably, it reduces damage due to ischemia-reperfusion injury in lung, liver, and brain in animal models of transplant, infection, traumatic brain injury, and stroke.

B2024 | Edaravone DataSheet

Alternate Name/Synonyms: 3-Methyl-1-phenyl-2-pyrazolin-5-one; NSC2629; MCI-186

Appearance: Light yellow solid

Formulation: N/A

CAS Number: 89-25-8

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₀H₁₀N₂O

Molecular Weight: 174.2

Cell-Permeable?: Yes

Purity: ≥98%

Solubilities: DMSO (>15 mg/ml)

Handling: Protect from air and light

Country of Origin: USA

Tag Line: An antioxidant

MDL Number: MFCD00003138

PubChem CID: 4021

SMILES: CC1=NN(C(=O)C1)C2=CC=CC=C2

InChi: nChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3

InChi Key: QELUYTUMUWHWMC-UHFFFAOYSA-N